AAAAAA

   
Results: 1-25 | 26-45 |
Results: 26-45/45
SERUM LEVELS OF GAMMA-INTERFERON IN PATIENTS WITH DOWNS-SYNDROME
Authors: TORRE D BROGGINI M ZEROLI C AGRIFOGLIO L BOTTA V CASALONE R FERRARIO G
Citation: D. Torre et al., SERUM LEVELS OF GAMMA-INTERFERON IN PATIENTS WITH DOWNS-SYNDROME, Infection, 23(1), 1995, pp. 66-67
SEQUENCE-SPECIFIC DNA INTERACTIONS BY NOVEL ALKYLATING ANTHRACYCLINE DERIVATIVES
Authors: MARCHINI S PAZ OG RIPAMONTI M GERONI C BARGIOTTI A CARUSO M TODESCHI S DINCALCI M BROGGINI M
Citation: S. Marchini et al., SEQUENCE-SPECIFIC DNA INTERACTIONS BY NOVEL ALKYLATING ANTHRACYCLINE DERIVATIVES, Anti-cancer drug design, 10(8), 1995, pp. 641-653
DIFFERENTIAL EXPRESSION OF C-FOS PROTOONCOGENE IN 2 SUBCLONES DERIVEDFROM A HUMAN OVARIAN-CANCER CELL-LINE
Authors: CATTABENI M DINCALCI M BROGGINI M
Citation: M. Cattabeni et al., DIFFERENTIAL EXPRESSION OF C-FOS PROTOONCOGENE IN 2 SUBCLONES DERIVEDFROM A HUMAN OVARIAN-CANCER CELL-LINE, Cellular and molecular biology, 41(2), 1995, pp. 255-263
DECREASED CYTOTOXIC EFFECTS OF DOXORUBICIN IN A HUMAN OVARIAN CANCER-CELL LINE EXPRESSING WILD-TYPE P53 AND WAF1 CIP1 GENES/
Authors: VIKHANSKAYA F DINCALCI M BROGGINI M
Citation: F. Vikhanskaya et al., DECREASED CYTOTOXIC EFFECTS OF DOXORUBICIN IN A HUMAN OVARIAN CANCER-CELL LINE EXPRESSING WILD-TYPE P53 AND WAF1 CIP1 GENES/, International journal of cancer, 61(3), 1995, pp. 397-401
LONG-TERM TOLERABILITY OF NASAL SPRAY FORMULATION OF SALMON-CALCITONIN
Authors: FOTI R MARTORANA U BROGGINI M
Citation: R. Foti et al., LONG-TERM TOLERABILITY OF NASAL SPRAY FORMULATION OF SALMON-CALCITONIN, Current therapeutic research, 56(4), 1995, pp. 429-435
DIFFERENT VIMENTIN EXPRESSION IN 2 CLONES DERIVED FROM A HUMAN COLOCARCINOMA CELL-LINE (LOVO) SHOWING DIFFERENT SENSITIVITY TO DOXORUBICIN
Authors: CONFORTI G CODEGONI AM SCANZIANI E DOLFINI E DASDIA T CALZA M CANIATTI M BROGGINI M
Citation: G. Conforti et al., DIFFERENT VIMENTIN EXPRESSION IN 2 CLONES DERIVED FROM A HUMAN COLOCARCINOMA CELL-LINE (LOVO) SHOWING DIFFERENT SENSITIVITY TO DOXORUBICIN, British Journal of Cancer, 71(3), 1995, pp. 505-511
CHROMOSOME CHANGES IN LYMPHOCYTES OF PATIENTS WITH SCLERODERMA
Authors: CASALONE R GRANATA P MINELLI E RIGHI R MERONI E MAZZOLA D SAMMARELLI G BARATELLI E BROGGINI M
Citation: R. Casalone et al., CHROMOSOME CHANGES IN LYMPHOCYTES OF PATIENTS WITH SCLERODERMA, Annales de genetique, 38(3), 1995, pp. 145-150
SPECIAL CONFERENCE ON GROWTH-FACTORS, DEVELOPMENT AND CANCER - INTERLAKEN, SWITZERLAND, MARCH 5-11, 1994 - COMMENTARY
Authors: BROGGINI M
Citation: M. Broggini, SPECIAL CONFERENCE ON GROWTH-FACTORS, DEVELOPMENT AND CANCER - INTERLAKEN, SWITZERLAND, MARCH 5-11, 1994 - COMMENTARY, Annals of oncology, 5(7), 1994, pp. 575-577
LORNOXICAM VERSUS DICLOFENAC IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, MULTICENTER STUDY
Authors: CARUSO I MONTRONE F BOARI L DAVOLI C BEYENE NB CAPORALI R GANDINI R FUMAGALLI M BARATELLI E BROGGINI M CANESI MB MUSCARA M MANZONI A LOCATI M DINGIANNA E FIORENTINI F
Citation: I. Caruso et al., LORNOXICAM VERSUS DICLOFENAC IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, MULTICENTER STUDY, Advances in therapy, 11(3), 1994, pp. 132-138
SUN EXPOSURE AND THE POLYMYALGIA RHEUMATICA-GIANT CELL ARTERITIS COMPLEX
Authors: CIMMINO MA ACCARDO S MONTECUCCO C CAPORALI R CAPPELLI A BROGGINI M
Citation: Ma. Cimmino et al., SUN EXPOSURE AND THE POLYMYALGIA RHEUMATICA-GIANT CELL ARTERITIS COMPLEX, Clinical and experimental rheumatology, 12(2), 1994, pp. 229-230
INTRODUCTION OF WILD-TYPE P53 IN A HUMAN OVARIAN-CANCER CELL-LINE NOTEXPRESSING ENDOGENOUS P53
Authors: VIKHANSKAYA F ERBA E DINCALCI M BROGGINI M
Citation: F. Vikhanskaya et al., INTRODUCTION OF WILD-TYPE P53 IN A HUMAN OVARIAN-CANCER CELL-LINE NOTEXPRESSING ENDOGENOUS P53, Nucleic acids research, 22(6), 1994, pp. 1012-1017
MODULATION OF TRANSCRIPTION FACTOR-DNA INTERACTIONS BY ANTICANCER DRUGS
Authors: BROGGINI M DINCALCI M
Citation: M. Broggini et M. Dincalci, MODULATION OF TRANSCRIPTION FACTOR-DNA INTERACTIONS BY ANTICANCER DRUGS, Anti-cancer drug design, 9(4), 1994, pp. 373-387
L1210 CELLS SELECTED FOR RESISTANCE TO METHOXYMORPHOLINYL DOXORUBICINAPPEAR SPECIFICALLY RESISTANT TO THIS CLASS OF MORPHOLINYL DERIVATIVES
Authors: GERONI C PESENTI E BROGGINI M BELVEDERE G TAGLIABUE G DINCALCI M PENNELLA G GRANDI M
Citation: C. Geroni et al., L1210 CELLS SELECTED FOR RESISTANCE TO METHOXYMORPHOLINYL DOXORUBICINAPPEAR SPECIFICALLY RESISTANT TO THIS CLASS OF MORPHOLINYL DERIVATIVES, British Journal of Cancer, 69(2), 1994, pp. 315-319
TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH CONTINUOUS DAILY ORAL ALENDRONATE IN COMPARISON WITH EITHER PLACEBO OR INTRANASAL SALMON-CALCITONIN
Authors: ADAMI S BARONI MC BROGGINI M CARRATELLI L CARUSO I GNESSI L LAURENZI M LOMBARDI A NORBIATO G ORTOLANI S RICERCA E ROMANINI L SUBRIZI S WEINBERG J YATES AJ
Citation: S. Adami et al., TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH CONTINUOUS DAILY ORAL ALENDRONATE IN COMPARISON WITH EITHER PLACEBO OR INTRANASAL SALMON-CALCITONIN, Osteoporosis international, 3, 1993, pp. 190000021-190000027
MULTICENTER STUDY OF THE SAFETY EFFICACY OF MISOPROSTOL IN THE PREVENTION AND TREATMENT OF NSAID-INDUCED GASTRODUODENAL LESIONS
Authors: GRAZIOLI I AVOSSA M BOGLIOLO A BROGGINI M CARCASSI A CARCASSI U CECCONAMI L LIGNIERE GC COLOMBO B CONSOLI G DIMATTEO L FIORAVANTI A FRIZZIERO L LAMONTAGNA G LAPADULA G MACARRI G MANGIAMELI A MARCOLONGO R PERPIGNANO G PIPITONE V QUATTROCCHI G SAGGIORO A TIRRI G TODESCO S
Citation: I. Grazioli et al., MULTICENTER STUDY OF THE SAFETY EFFICACY OF MISOPROSTOL IN THE PREVENTION AND TREATMENT OF NSAID-INDUCED GASTRODUODENAL LESIONS, Clinical and experimental rheumatology, 11(3), 1993, pp. 289-294
HEPATITIS-B AND C INFECTION IN AN INSTITUTION FOR THE MENTALLY-HANDICAPPED
Authors: TORRE D GIOLA M ZEROLI C FERRARIO G BROGGINI M AGRIFOGLIO L BOTTA V
Citation: D. Torre et al., HEPATITIS-B AND C INFECTION IN AN INSTITUTION FOR THE MENTALLY-HANDICAPPED, Infection, 21(6), 1993, pp. 410-411
SHORT COURSES OF INTRAVENOUS CLODRONATE IN THE TREATMENT OF PAGETS-DISEASE OF BONE - A LONG-TERM FOLLOW-UP TRIAL
Authors: BROGGINI M BARATELLI E CAPPELLI A MARCONI A GHIRINGHELLI D SALZILLO A
Citation: M. Broggini et al., SHORT COURSES OF INTRAVENOUS CLODRONATE IN THE TREATMENT OF PAGETS-DISEASE OF BONE - A LONG-TERM FOLLOW-UP TRIAL, International journal of clinical pharmacology research, 13(6), 1993, pp. 301-304
EFFECTS OF DNA-DAMAGING AGENTS ON GENE-EXPRESSION IN 2 HUMAN CANCER CELL-LINES
Authors: VIKHANSKAYA F DINCALCI M BROGGINI M
Citation: F. Vikhanskaya et al., EFFECTS OF DNA-DAMAGING AGENTS ON GENE-EXPRESSION IN 2 HUMAN CANCER CELL-LINES, Cellular and molecular biology, 39(8), 1993, pp. 855-862
DIFFERENTIAL INHIBITION OF THE DNA-BINDING OF TRANSCRIPTION FACTORS NF-KAPPA-B AND OTF-1 BY NITROGEN-MUSTARD AND QUINACRINE MUSTARD - TRANSCRIPTIONAL IMPLICATIONS
Authors: FABBRI S PRONTERA C BROGGINI M DINCALCI M
Citation: S. Fabbri et al., DIFFERENTIAL INHIBITION OF THE DNA-BINDING OF TRANSCRIPTION FACTORS NF-KAPPA-B AND OTF-1 BY NITROGEN-MUSTARD AND QUINACRINE MUSTARD - TRANSCRIPTIONAL IMPLICATIONS, Carcinogenesis, 14(9), 1993, pp. 1963-1967
CHARACTERIZATION OF A LOVO SUBLINE RESISTANT TO A BENZOYL MUSTARD DERIVATIVE OF DISTAMYCIN-A (FCE 24517)
Authors: CAPOLONGO L MELEGARO G BROGGINI M MONGELLI N GRANDI M
Citation: L. Capolongo et al., CHARACTERIZATION OF A LOVO SUBLINE RESISTANT TO A BENZOYL MUSTARD DERIVATIVE OF DISTAMYCIN-A (FCE 24517), British Journal of Cancer, 68(5), 1993, pp. 916-919
Risultati: 1-25 | 26-45 |